CIK 0001689548 · Large accelerated filer
Praxis Precision Medicines, Inc.
Sign in to watch- Ticker
- PRAX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-300-8460
- Business address
- 99 HIGH STREET, 30TH FLOOR, BOSTON, MA, 02110
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-11-20 | Nemiroff Alex General Counsel and Secretary | Option exercise · Stock Option (Right to Buy) | −2,434 | 0 | ||
| 2025-11-20 | Nemiroff Alex General Counsel and Secretary | Option exercise · Stock Option (Right to Buy) | −5,652 | 2,347 | ||
| 2025-11-20 | Nemiroff Alex General Counsel and Secretary | Option exercise · Stock Option (Right to Buy) | −9,100 | 19,717 | ||
| 2025-11-20 | Mastrocola Lauren Principal Accounting Officer | Option exercise | +1,047 | $49.50 | $52K | 11,488.66 |
| 2025-11-20 | Mastrocola Lauren Principal Accounting Officer | Option exercise | +508 | $83.85 | $43K | 11,996.66 |
| 2025-11-20 | Mastrocola Lauren Principal Accounting Officer | Option exercise | +1,557 | $133.65 | $208K | 13,553.66 |
| 2025-11-20 | Mastrocola Lauren Principal Accounting Officer | Option exercise | +2,680 | $43.37 | $116K | 16,233.66 |
| 2025-11-20 | Mastrocola Lauren Principal Accounting Officer | Option exercise | +207 | $44.40 | $9K | 16,440.66 |
| 2025-11-20 | Mastrocola Lauren Principal Accounting Officer | Option exercise | +2,351 | $44.40 | $104K | 18,791.66 |
| 2025-11-20 | Mastrocola Lauren Principal Accounting Officer | Option exercise | +5,250 | $56.94 | $299K | 24,041.66 |
| 2025-11-20 | Mastrocola Lauren Principal Accounting Officer | Sale | −11,455 | $191.96 | $2.2M | 12,586.66 |
| 2025-11-20 | Mastrocola Lauren Principal Accounting Officer | Sale | −2,145 | $192.71 | $413K | 10,441.66 |
| 2025-11-20 | Mastrocola Lauren Principal Accounting Officer | Option exercise · Stock Option (Right to Buy) | −1,047 | 0 | ||
| 2025-11-20 | Mastrocola Lauren Principal Accounting Officer | Option exercise · Stock Option (Right to Buy) | −508 | 0 | ||
| 2025-11-20 | Mastrocola Lauren Principal Accounting Officer | Option exercise · Stock Option (Right to Buy) | −1,557 | 0 | ||
| 2025-11-20 | Mastrocola Lauren Principal Accounting Officer | Option exercise · Stock Option (Right to Buy) | −2,680 | 9,320 | ||
| 2025-11-20 | Mastrocola Lauren Principal Accounting Officer | Option exercise · Stock Option (Right to Buy) | −207 | 0 | ||
| 2025-11-20 | Mastrocola Lauren Principal Accounting Officer | Option exercise · Stock Option (Right to Buy) | −2,351 | 981 | ||
| 2025-11-20 | Mastrocola Lauren Principal Accounting Officer | Option exercise · Stock Option (Right to Buy) | −5,250 | 11,376 | ||
| 2025-11-14 | Kelly Timothy Edwin Chief Financial Officer | Grant or award | +384 | $31.62 | $12K | 24,663 |
Page 5 of 17 · 331 trades